Phase I trial of BTP 277 in patients with cancer

Trial Profile

Phase I trial of BTP 277 in patients with cancer

Planning
Phase of Trial: Phase I

Latest Information Update: 15 Apr 2015

At a glance

  • Drugs BTP 277 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Sponsors Tarveda Therapeutics
  • Most Recent Events

    • 15 Apr 2015 New trial record
    • 13 Apr 2015 Blend Therapeutics plans to file an IND application for this trial with the US FDA in early 2016, according to a media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top